Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole
Revista Iberoamericana de Micología · 2015-10 · 32 (4) · 214-220
DOI: 10.1016/j.riam.2014.07.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Iberoamericana de Micología, 2015-10. Verfasst von Carlos Andrés Agudelo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, Universidad Pontificia Bolivariana, Calle 78b No. 72(A)-109, Medellín, Colombia. Electronic address: carlosagudelo@yahoo.c…. Hauptthemen laut MEDLINE: Drug Resistance, Fungal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The implications of the Cryptococcus neoformans resistance to fluconazole on patient therapy have not been fully elucidated due to the discordant results found in published studies. AIMS: To establish the influence of C. neoformans resistance to fluconazole in the therapy of individuals with cryptococcosis and AIDS. METHODS: This study retrospectively compared the clinical course of patients with cryptococcosis according to the level of fluconazole resistance of their C. neoformans isolates. RESULTS: This study included 71 episodes of cryptococcosis, defined as those isolates of C. neoformans obtained from patients with mycosis, of which 36 isolates were sensitive to fluconazole, 20 susceptible dose-dependent (SDD), and 15 were resistant. There were 5 treatment failures in the consolidation phase; two occurred in patients who had a susceptible strain, 2 in patients who had SDD strains, and one in a patient who had a resistant strain. During the maintenance treatment, relapses occurred in 4 of 33 patients (12%), seen during the follow-up period, none of which occurred in the group with resistant isolates. There were no significant differences in survival time free of treatment failure (p=0.65) or survival time free of failure or relapse (p=0.38). These results were not affected when tested in a Cox model that included age, CD4T lymphocyte counts, and use of antiretroviral therapy. CONCLUSIONS: In HIV patients with cryptococcosis, the resistance of C. neoformans appeared not to increase the risk of failure or relapse during treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Sciences, Universidad Pontificia Bolivariana, Calle 78b No. 72(A)-109, Medellín, Colombia. Electronic address: carlosagudelo@yahoo.com.
- School of Health Sciences, Universidad Pontificia Bolivariana, Calle 78b No. 72(A)-109, Medellín, Colombia.
- Medical and Experimental Mycology Unit, Corporación para Investigaciones Biológicas, Carrera 72(A) No. 78(B)-141, Medellín, Colombia.
Zitieren
APA
Agudelo, C. A., Muñoz, C., Ramírez, A., Tobón, A. M., de Bedout Bact, C., Cano, L. E., & Restrepo, A. (2015). Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole. Revista Iberoamericana de Micología, 32(4), 214-220. https://doi.org/10.1016/j.riam.2014.07.006
Vancouver
Agudelo CA, Muñoz C, Ramírez A, Tobón AM, de Bedout Bact C, Cano LE, et al. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole. Revista Iberoamericana de Micología. 2015;32(4):214-220. doi:10.1016/j.riam.2014.07.006
BibTeX
@article{Agudelo2015,
author = {Agudelo, Carlos Andrés and Muñoz, Carolina and Ramírez, Alex and Tobón, Angela María and de Bedout Bact, Catalina and Cano, Luz Elena and Restrepo, Angela},
title = {Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole},
journal = {Revista Iberoamericana de Micología},
year = {2015},
volume = {32},
number = {4},
pages = {214--220},
doi = {10.1016/j.riam.2014.07.006}
}
EUVIMED